Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD

  Рет қаралды 10,472

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
Common CMC Issues in Type II DMFs and How to Avoid Them
26:19
U.S. Food and Drug Administration
Рет қаралды 2,9 М.
Decrease RTR, IR, and CR Due to Dissolution Deficiencies (21of28) GDF - Apr. 3-4, 2019
35:21
U.S. Food and Drug Administration
Рет қаралды 1,8 М.
Don’t Choose The Wrong Box 😱
00:41
Topper Guild
Рет қаралды 62 МЛН
Sigma Kid Mistake #funny #sigma
00:17
CRAZY GREAPA
Рет қаралды 30 МЛН
Chain Game Strong ⛓️
00:21
Anwar Jibawi
Рет қаралды 41 МЛН
Каха и дочка
00:28
К-Media
Рет қаралды 3,4 МЛН
Safety Evaluation of Drug Substance Impurities in Generics
21:51
U.S. Food and Drug Administration
Рет қаралды 2,9 М.
New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment (2 of 2)
2:02:52
CMC Considerations for CAR T Cell Product Development
29:42
U.S. Food and Drug Administration
Рет қаралды 12 М.
Application of (Q)SAR and Expert Knowledge for ICH M7 Impurity Classification
25:35
U.S. Food and Drug Administration
Рет қаралды 3,8 М.
Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI - May 29-30, 2019
55:56
U.S. Food and Drug Administration
Рет қаралды 12 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session Two
1:42:25
U.S. Food and Drug Administration
Рет қаралды 667
ICH M7(R1) - Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment
20:33
U.S. Food and Drug Administration
Рет қаралды 7 М.
Is My Product A Medical Device
24:00
U.S. Food and Drug Administration
Рет қаралды 18 М.
Panel Discussion - Drug Master File and Drug Substance Workshop
28:33
U.S. Food and Drug Administration
Рет қаралды 340
Questions and Answers on Drug Master Files (DMFs) and Drug Substances Part II
1:23:05
U.S. Food and Drug Administration
Рет қаралды 2,6 М.
Don’t Choose The Wrong Box 😱
00:41
Topper Guild
Рет қаралды 62 МЛН